52,884 Shares in Relx Plc $RELX Acquired by Tealwood Asset Management Inc.

Tealwood Asset Management Inc. bought a new position in shares of Relx Plc (NYSE:RELX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 52,884 shares of the technology company’s stock, valued at approximately $2,138,000.

A number of other hedge funds have also bought and sold shares of the stock. JPMorgan Chase & Co. grew its holdings in shares of Relx by 18.0% during the third quarter. JPMorgan Chase & Co. now owns 1,007,921 shares of the technology company’s stock valued at $48,138,000 after buying an additional 153,821 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of Relx in the 3rd quarter valued at $1,441,000. Allworth Financial LP raised its stake in Relx by 38.3% in the 3rd quarter. Allworth Financial LP now owns 2,503 shares of the technology company’s stock worth $120,000 after acquiring an additional 693 shares during the last quarter. Investment Research Partners LLC acquired a new stake in Relx during the 3rd quarter worth about $454,000. Finally, CIBC Private Wealth Group LLC lifted its position in Relx by 92.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 3,015 shares of the technology company’s stock worth $144,000 after acquiring an additional 1,446 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on RELX. Deutsche Bank Aktiengesellschaft raised Relx from a “hold” rating to a “buy” rating in a report on Tuesday, December 9th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Relx in a report on Monday, December 29th. Zacks Research lowered Relx from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Citigroup started coverage on shares of Relx in a report on Monday, January 12th. They issued a “neutral” rating on the stock. Finally, Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Relx presently has a consensus rating of “Moderate Buy”.

Relx Price Performance

NYSE:RELX opened at $33.34 on Friday. Relx Plc has a one year low of $27.57 and a one year high of $56.33. The company has a quick ratio of 0.44, a current ratio of 0.49 and a debt-to-equity ratio of 2.38. The firm’s fifty day moving average is $34.75 and its two-hundred day moving average is $40.44.

Relx (NYSE:RELX) last released its quarterly earnings data on Thursday, February 12th. The technology company reported $0.43 earnings per share for the quarter, missing analysts’ consensus estimates of $0.85 by ($0.42). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $6.70 billion. As a group, equities analysts forecast that Relx Plc will post 1.68 EPS for the current fiscal year.

Relx Dividend Announcement

The business also recently announced a dividend, which will be paid on Wednesday, June 24th. Investors of record on Friday, May 8th will be issued a dividend of $0.6559 per share. This represents a yield of 422.0%. The ex-dividend date of this dividend is Friday, May 8th.

About Relx

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.